Table 4.
Outcomes, length of stay and therapeutics (n = 162)
| Variables | Median or percentage | |
|---|---|---|
| SOFA at 48 h | 5 | [3–8] |
| No Ventilation | 33 | (20.4) |
| Non-invasive ventilation | 9 | (5.6) |
| Median days | 4 | [3–7] |
| High-flow nasal oxygen therapy | 21 | (13) |
| Median days | 4 | [2–5] |
| NIV and HFOT | 4 | (2.5) |
| Median days | 1.5 | [1-2.5] |
| Invasive ventilation | 95 | (58.6) |
| Median days | 10 | [6–17] |
| Invasive ventilation at admission (n = 95) | 79 | (83.2) |
| Invasive ventilation after 24 h (n = 95) | 16 | (16.8) |
| Median days ventilation/admission | 2.5 | [2-3.5] |
| Acute respiratory distress syndrome | 73 | (45.1) |
| Paralysis for ARDS (n = 73) | 65 | (85) |
| Prone position for ARDS (n = 73) | 39 | (53.4) |
| Extracorporeal membrane oxygenation | 8 | (4.9) |
| Vasopressors | 84 | (51.9) |
| Renal replacement therapy | 27 | (16.7) |
| Median days | 6.5 | [3–12] |
| Combination therapy antibiotics | 128 | (79.1) |
| Median days | 10 | [7–15] |
| Mono-therapy antibiotic | 33 | (20.4) |
| Antibiotherapy median days | 18 | [14–21] |
| No antibiotics | 1 | (0.6) |
| No antibiotics at ICU admission | 6 | |
| Median days antibiotic/hospitalization | 0 | [0–1] |
| Median days antibiotic/ICU | 0 | [0–0] |
| No antibiotics at ICU admission | 6 | (3.7) |
| Median days diagnosis/hospitalization | 1 | [0–2] |
| Median days of ICU | 11 | [5–19] |
| Median days of hospitalization | 17 | [10–29] |
| 28-day mortality | 19 | (11.7) |
| ICU mortality | 21 | (13) |
| Hospital mortality | 22 | (13.6) |
Data are presented as No (%) or median (Q1-Q3) unless otherwise indicate
NIV a non-invasive ventilation
HFOT high-flow nasal oxygen therapy
ARDS acute respiratory distress syndrome
Extracorporeal membrane oxygenation corresponds to veno-venous extracorporeal membrane oxygenation